Neoplasm Risk in Rheumatic Diseases Has No Correlation With Conventional Synthetic Disease-Modifying Anti-rheumatic Drugs Usage—A Population-Based Nested Case–Control Study

Objectives: To investigate whether there is an elevated neoplasm risk in patients with rheumatic diseases treated with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs). Methods: A population-based nested case–control study was performed by retrieving all patients newly diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Shaozhe, Perng, Wuu-Tsun, Huang, Jing Y., Chiou, Jeng-Yuan, Dong, Lingli, Wei, James C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479172/
https://www.ncbi.nlm.nih.gov/pubmed/32984368
http://dx.doi.org/10.3389/fmed.2020.00473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479172/
https://www.ncbi.nlm.nih.gov/pubmed/32984368
http://dx.doi.org/10.3389/fmed.2020.00473

Ejemplares similares